L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea · Delayed Price · Currency is KRW

62,600

-2,200 (-3.40%)

May 20, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medical Products	85.48B	72.03B	65.93B	52.57B	45.68B
Medical Products Growth	18.66%	9.26%	25.40%	15.10%	38.53%
Total	85.48B	72.03B	65.93B	52.57B	45.68B
Total Growth	18.66%	9.26%	25.40%	15.10%	38.53%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Overseas	5.98B	4.58B	3.94B	3.90B	2.22B
Overseas Growth	30.42%	16.42%	0.93%	75.28%	-
South Korea	79.50B	67.45B	61.99B	48.67B	43.45B
South Korea Growth	17.87%	8.81%	27.36%	12.01%	-
Total	85.48B	72.03B	65.93B	52.57B	45.68B
Total Growth	18.66%	9.26%	25.40%	15.10%	-

Source: S&P Global Market Intelligence.